Rare disease study seeks to map MLIV's natural history
NCT ID NCT01067742
First seen Feb 01, 2026 · Last updated May 17, 2026 · Updated 18 times
Summary
This study aimed to understand how Mucolipidosis Type IV (MLIV) progresses over time in affected individuals. Researchers observed 7 participants through tests like neuropsychological exams, blood and urine tests, and MRI scans. The goal was to identify useful measures for future clinical trials, not to test a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCOLIPIDOSIS TYPE IV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Institute of Metabolic Disease
Dallas, Texas, 75226, United States
Conditions
Explore the condition pages connected to this study.